IL242438B - Dosage form soft pharmaceutical gelatin capsule - Google Patents

Dosage form soft pharmaceutical gelatin capsule

Info

Publication number
IL242438B
IL242438B IL242438A IL24243815A IL242438B IL 242438 B IL242438 B IL 242438B IL 242438 A IL242438 A IL 242438A IL 24243815 A IL24243815 A IL 24243815A IL 242438 B IL242438 B IL 242438B
Authority
IL
Israel
Prior art keywords
dosage form
gelatin capsule
soft gelatin
capsule dosage
pharmaceutical soft
Prior art date
Application number
IL242438A
Other languages
English (en)
Hebrew (he)
Original Assignee
Warner Chilcott Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Co Llc filed Critical Warner Chilcott Co Llc
Publication of IL242438B publication Critical patent/IL242438B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL242438A 2013-03-15 2015-11-04 Dosage form soft pharmaceutical gelatin capsule IL242438B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361794813P 2013-03-15 2013-03-15
PCT/US2014/027093 WO2014152226A1 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form

Publications (1)

Publication Number Publication Date
IL242438B true IL242438B (en) 2020-01-30

Family

ID=50391548

Family Applications (1)

Application Number Title Priority Date Filing Date
IL242438A IL242438B (en) 2013-03-15 2015-11-04 Dosage form soft pharmaceutical gelatin capsule

Country Status (11)

Country Link
US (1) US20140271837A1 (enExample)
EP (1) EP2968183B1 (enExample)
JP (1) JP6335269B2 (enExample)
CN (1) CN105392476B (enExample)
AU (1) AU2014240039B2 (enExample)
CA (1) CA2906619C (enExample)
ES (1) ES2681982T3 (enExample)
HK (1) HK1220113A1 (enExample)
IL (1) IL242438B (enExample)
MX (1) MX376951B (enExample)
WO (1) WO2014152226A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3031628B2 (ja) 1990-04-07 2000-04-10 株式会社日立製作所 洗濯乾燥機
JP3143355B2 (ja) 1995-03-28 2001-03-07 三洋電機株式会社 遠心脱水装置
US10673198B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-coupled laser with time varying beam characteristics
US10673199B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based saturable absorber
US10673197B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based optical modulator
CA3201467A1 (en) * 2020-11-13 2022-05-19 Pfizer Inc. Talazoparib soft gelatin capsule dosage form

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US5102666A (en) * 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
AU1925697A (en) * 1996-03-12 1997-10-01 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
WO2005070950A1 (en) 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
MXPA06007852A (es) 2004-01-15 2007-01-31 Warner Chilcott Co Inc Profarmacos di-esteroidales de estradiol.
CA2612380C (en) 2005-06-16 2017-06-06 Warner Chilcott Company, Inc. Estrogen compositions for vaginal administration
WO2007008474A2 (en) 2005-07-12 2007-01-18 Warner Chilcott Company, Inc. 3 -ester prodrugs of estradiol
ES2523045T3 (es) 2005-07-12 2014-11-20 Warner Chilcott Company, Llc Derivado éster de etinil estradiol
WO2007050975A2 (en) * 2005-10-26 2007-05-03 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system as capsule fill
US20070104778A1 (en) * 2005-11-07 2007-05-10 Hongxia Zeng Controlled-release emulsion compositions
EP2011496A1 (en) * 2007-07-03 2009-01-07 Indena S.P.A. Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions

Also Published As

Publication number Publication date
CN105392476A (zh) 2016-03-09
MX376951B (es) 2025-03-07
MX2015012075A (es) 2016-05-10
CA2906619A1 (en) 2014-09-25
WO2014152226A1 (en) 2014-09-25
US20140271837A1 (en) 2014-09-18
CN105392476B (zh) 2018-11-02
AU2014240039A1 (en) 2015-10-15
EP2968183A1 (en) 2016-01-20
EP2968183B1 (en) 2018-05-09
JP6335269B2 (ja) 2018-05-30
AU2014240039B2 (en) 2019-01-24
JP2016513680A (ja) 2016-05-16
CA2906619C (en) 2021-11-16
ES2681982T3 (es) 2018-09-17
HK1220113A1 (zh) 2017-04-28

Similar Documents

Publication Publication Date Title
IL240518A0 (en) Capsule for single use and system
EP3750590C0 (en) THRESHOLD RELEASE ADMINISTRATION CAPSULE
IL246377A0 (en) Pharmaceutical preparations for oral administration
PT3043773T (pt) Composição farmacêutica de dose fixa estável composta por mometasona e olopatadina para administração nasal
ZA201403276B (en) Low dose pharmaceutical composition
GB201310263D0 (en) Burial capsule
ZA201507576B (en) Pharmaceutical combination drug
IL242438B (en) Dosage form soft pharmaceutical gelatin capsule
IL241377B (en) Dosage form soft pharmaceutical gelatin capsule with modified guar resin
DK2964193T3 (da) Lægemidler til oral indgivelse
SG11201509194SA (en) Radiomitigating pharmaceutical formulations
IL245705A0 (en) Pharmaceutical dosage forms
GB201318686D0 (en) Pharmaceutical preparations
ZA201600027B (en) Pharmaceutical preparation
GB201301721D0 (en) Pharmaceutical Preparations
GB201305103D0 (en) An oral dosage form
EP2979698A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
UA28330S (uk) Капсула для лікарського засобу
ITLU20130005U1 (it) Svita capsule
ZA201506465B (en) Pharmaceutical preparation
AU358389S (en) Pharmaceutical capsule
GB201309971D0 (en) Oral medicines syringe
TH1401006080A (th) สูตรผสมยาแคปซูล
HU4589U (en) Capsule
TH1401005685A (th) องค์ประกอบยาและยาแคปซูลชนิดอ่อนที่ปิดผนึกองค์ประกอบยาดังกล่าว

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed